Dr. Nduka Mgbechinyere Amankulor, MD

Dr. Amankulor practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Amankulor's NPI, 1033386792, was assigned on May 13, 2008. Dr. Amankulor graduated from Yale School of Medicine in 2004. Dr. Amankulor holds Pennsylvania license MD446087.

Dr. Amankulor's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Amankulor's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Amankulor is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Amankulor to 1 more hospital, 3 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account. Dr. Amankulor's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amankulor practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Amankulor's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Amankulor is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Amankulor's licenses on file in 3 states: Pennsylvania, New Jersey and New York.

Dmand AI lists craniotomy among the conditions Dr. Amankulor treats.

CMS data shows 162 Medicare services from Dr. Amankulor across 8 procedure codes in 2024, for 63 Medicare patients. Medicare paid $71,649 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Amankulor in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amankulor's median patient age at 58, with 51% women.

In 2021, Dr. Amankulor wrote 78 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $2,708 in total drug cost. In 2020, CMS named 130 claims across 4 drugs.

Dr. Amankulor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amankulor as offering telehealth.

Dmand AI links 65 papers to Dr. Amankulor, published from 2007 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Glioma and Glioblastoma. Dr. Amankulor has published most often in Neuro Oncol. Dr. Amankulor's most frequent co-authors are Pascal Olivier Zinn, MD, PhD, William Christopher Newman, MD and Hideho Okada, MD.

Dmand AI links Dr. Amankulor to 1 clinical trial.

CMS Open Payments shows 16 general payments to Dr. Amankulor from 7 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 86% of the total. BK Medical Holding Company Inc. paid the most, $28,966.

Dmand AI lists 1 award for Dr. Amankulor, most recently CMS Stage 1 EHR in 2013.

Dr. Amankulor graduated from Yale School of Medicine in 2004. Dr. Amankulor is a member of CNS.

Dr. Amankulor is in network with 13 carriers, including United Healthcare, Cigna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.